Combined detection of circulating tumor cells, α-fetoprotein heterogene-3 and α-fetoprotein in the early diagnosis of HCC for the prediction of efficacy, prognosis, recurrence after microwave ablation

Table 2 Comparison of Serum AFP, AFP-L3 and CTCs Levels

Groups	n	AFP(ng/mL)	AFP-L3(%)	CTCs(/mL)
Normal control group	110	7.16(5.27~10.05)	5.32(3.63-7.07)	0
Hepatitis group	127	9.37(6.54~12.86)	6.45(4.51-8.15)	0.37(0-0.52)
Cirrhosis group	102	22.08(13.02~178.91)^a,b	12.73(9.07-15.32)^a,b	1.53(0.42-2.15)^a,b
HCC group	143	183.27(67.93~1512.34)^a,b,c	17.07(13.32-21.91)^a,b,c	2.47(1.95-2.93)^a,b,c
F		112.02	67.16	78.37
P		<0.001	<0.001	<0.001

Note: vs. normal control group, ^aP<0.05; vs. hepatitis group, ^bP<0.05; vs. the other groups, ^cP<0.05

ISSN: 1750-9378